Cataract Formation in a Child Receiving Dabrafenib and Trametinib Therapy

Summary

Bilateral cataracts developed in a 9-year-old girl treated with targeted therapy drugs dabrafenib and trametinib. This is the first reported case of cataracts as a complication of this specific cancer treatment.